CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 186 enrolled
Drug / intervention
API 31510 3% Topical Cream +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00604890
NCT00604890Phase 2Completed
CompareCT.gov

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

BPGbio·interventional·Posted Jan 30, 2008·Updated Feb 28, 2025

In Brief

A Phase 2 clinical trial evaluating API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, and 1 other intervention for Superficial Basal Cell Carcinoma. Completed, enrolled 186 participants across 11 sites.

Detailed Summary

The purpose of this study is to determine the safety and tolerability of pharmaceutical compound (API 31510) topical cream topically applied to superficial basal cell carcinomas to obtain preliminary efficacy data for the treatment of superficial basal cell carcinomas by API 31510 topical cream. The study population will include one hundred and sixty (160) otherwise healthy male or female adults with one or more histologically confirmed superficial basal cell carcinoma lesions. One target lesion with an area of less than one inch will be designated for study treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSuperficial Basal Cell Carcinoma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 30, 2008
Enrollment StartMar 1, 2008
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.4 years ago

Interventions

API 31510 3% Topical Creamdrug

Topical treatment 3% active cream applied to the lesion

API 31510 1.5% Topical Creamdrug

Topical treatment 1.5% active cream applied to the lesion

Placeboother

Topical treatment placebo applied to the lesion